Nirogy Therapeutics

Nirogy Therapeutics is a Massachusetts-based biotechnology company dedicated to developing novel small molecules targeting cellular transporters. The company is currently advancing a class of small molecules designed to disrupt metabolic and immune mechanisms within the tumor microenvironment. The goal of subsequent platform programs is to target additional disease pathways in oncology and autoimmune diseases.